If you’re a healthcare provider, practice owner, or medical executive, being named in a False Claims Act (FCA) lawsuit, especially a qui tam action, can be career-altering. These lawsuits often start quietly, with a whistleblower (known as a “relator”), often a private citizen, filing a sealed complaint on behalf of the federal government. But when unsealed, they can explode into a full-blown federal investigation that threatens your license, livelihood, and professional reputation.
The FCA allows the government or private citizens to file qui tam lawsuits and pursue civil penalties and treble damages from individuals or companies accused of submitting false claims for payment from federal programs like Medicare, Medicaid, or TRICARE. These qui tam claims are designed to recover federal funds lost to fraud. While the law was designed to combat large-scale fraud, it’s often used to target complex billing disputes, documentation lapses, or compliance gray areas particularly in healthcare.
At Chapman Law Group, we represent healthcare professionals nationwide who find themselves on the defense side of a qui tam action. Whether you’re a physician, pharmacist, clinic owner, or healthcare executive, our attorneys understand how FCA investigations unfold and how to aggressively defend against them. If you are named in a lawsuit, it is important to understand the process to file qui tam lawsuits under the FCA and the role of a qui tam whistleblower in bringing these actions.
A qui tam lawsuit, also known as a whistleblower lawsuit, is a legal action brought under the False Claims Act by a private individual, known as a relator (also referred to as a qui tam relator), who claims to have knowledge of fraudulent billing or improper conduct involving government funds. These lawsuits are filed under seal in federal court, which means the accused party often has no idea a case has been filed until months later when the government finishes its investigation and decides whether to intervene.
In healthcare, qui tam lawsuits are typically filed by former employees, competitors, billing contractors, or others with insider access. Many of these cases focus on allegations that a provider knowingly submitted false claims to federal healthcare programs like Medicare, Medicaid, or TRICARE.
Common allegations in healthcare-related qui tam lawsuits include:
Because the qui tam relator can receive between 15 to 30 percent of the government’s recovery, there is a strong financial incentive to bring these lawsuits even when the alleged conduct is the result of complex billing practices or unclear regulatory guidance. Whistleblowers may receive a percentage of the recovered funds as a reward for their role in exposing fraud.
If you are named in a qui tam lawsuit or believe you are being investigated in connection with one, it is essential to take the matter seriously. These cases often start as civil litigation but can evolve into criminal inquiries or administrative actions that threaten your license and ability to practice.
False Claims Act cases often begin where healthcare billing, documentation, or referral practices intersect with federal funding. What might initially appear to be a compliance issue can quickly escalate into a federal investigation, especially if a whistleblower alleges intentional misconduct.
These are some of the most common scenarios that lead to qui tam lawsuits against healthcare professionals:
In many cases, the provider is unaware that their billing or referral structure has come under scrutiny until a subpoena, civil investigative demand (CID), or interview request arrives. The earlier you identify the risk and begin developing a defense, the better your chances of avoiding intervention or minimizing liability.
These cases are rarely about simple fraud. Most involve technical billing standards, changing CMS guidance, or nuanced interpretations of medical necessity. That’s why it’s critical to have a defense team that understands both healthcare operations and federal enforcement. Beyond healthcare, the FCA is also used to address government contract fraud and to combat widespread fraud in government programs, reflecting its broad reach and historical purpose.
Under the False Claims Act (FCA), a false claim is any request or demand for payment or property made to the federal government or its agencies that is knowingly false or fraudulent. This means that if a healthcare provider, business, or organization submits a claim for reimbursement, such as for Medicare or Medicaid services that contains false information, omits key facts, or is otherwise misleading, it may be considered a violation of the False Claims Act.
The law is broad: a false claim doesn’t have to be an outright lie. It can also arise from reckless disregard or deliberate ignorance of the truth. In other words, if you submit a claim without verifying its accuracy, or ignore obvious red flags, you could still be held liable under the False Claims Act even if you didn’t intend to defraud the federal government.
Some common examples of false claims in healthcare include:
The False Claims Act also covers claims made to contractors, grantees, or other recipients if the funds are to be used on the government’s behalf. The key factor is whether the claim was made with actual knowledge of its falsity, with deliberate ignorance of the truth, or with reckless disregard for whether it was true or false.
Because the False Claims Act is designed to protect federal government funds, its reach extends beyond healthcare to areas like defense contracting and government procurement. However, healthcare professionals are among the most frequent targets due to the complexity and volume of federal program billing.
Understanding what constitutes a false claim, the standards of actual knowledge, reckless disregard, and deliberate ignorance, is essential for anyone who bills federal programs. Even honest mistakes can trigger FCA scrutiny if the government believes you should have known about the error.
Materiality is a cornerstone of the False Claims Act and a critical factor in defending against qui tam lawsuits. In simple terms, materiality asks: Was the alleged false or fraudulent conduct significant enough to influence the federal government’s decision to pay a claim?
Not every error or regulatory misstep rises to the level of a false claim under the FCA. For a qui tam lawsuit to succeed, the relator must show that the false statement or omission was material, in that it had a natural tendency to affect, or was capable of affecting, the government’s payment decision. This requirement helps ensure that only substantial, meaningful fraudulent conduct is actionable under the False Claims Act (FCA).
The Supreme Court’s decision in Universal Health Services, Inc. v. United States ex rel. Escobar made clear that materiality is a “demanding” standard. The government or relator must prove that the alleged false claims were important enough to warrant the government’s attention and could have influenced whether payment was made.
Key elements of materiality in FCA and qui tam lawsuits include:
For healthcare professionals facing a qui tam lawsuit, challenging materiality can be a powerful defense. If you can demonstrate that the alleged conduct was not significant enough to impact the government’s decision, or that the government routinely paid similar claims despite knowing about the issue, the case may be dismissed.
Effective defense strategies often include:
By focusing on materiality, you can shift the narrative from technical compliance errors to whether the alleged conduct truly mattered to the federal government. This approach is often decisive in defeating qui tam lawsuits and protecting your professional future.
Most healthcare professionals first learn about a qui tam lawsuit when contacted by federal agents, served with a subpoena, or informed that the Department of Justice is reviewing their billing practices. By that point, a whistleblower (relator) has already filed a sealed complaint on the government’s behalf in federal district court, and the government has been quietly investigating the allegations for months, sometimes more than a year.
After a qui tam complaint is filed, the government begins its own investigation, often involving federal agencies. This may include:
The government will then decide whether to pursue government intervention in the case. If the government intervenes, the Department of Justice will take over the litigation in federal district court. If the government declines or government declines to intervene, the relator can still proceed with the case privately in federal district court. Either way, once the case is unsealed, your name becomes public, and the litigation process begins.
Being named in a qui tam suit does not mean you are guilty of healthcare fraud. Many of these cases are built on flawed assumptions, misinterpreted data, or disgruntled whistleblowers with a financial incentive. However, the consequences can be severe if you don’t act quickly and strategically.
Your first priority should be retaining qui tam attorneys who understand both federal litigation, healthcare law, and the complexities of healthcare billing. Consulting with a qui tam attorney, especially an experienced qui tam attorney who specializes in False Claims Act cases is critical at the earliest stage. What you say or do in the first weeks can shape the government’s view of your role and intent. Their expertise can help protect your rights and guide you through each stage of the proceedings.
Defending against a qui tam lawsuit requires more than just general litigation experience. These cases often involve qui tam claims brought by whistleblowers alleging a fraudulent claim or multiple fraudulent claims submitted to the government. The allegations typically center on whether a provider knowingly submitted a fraudulent claim for payment, which is a violation of the False Claims Act. At Chapman Law Group, we focus exclusively on defending healthcare professionals, and our defense strategies reflect that depth of experience.
Some of the most effective defense strategies in FCA and qui tam cases include:
We also tailor our approach depending on whether the government has chosen to intervene. Pre-intervention strategies focus on persuading the Department of Justice not to adopt the case. Post-intervention strategies focus on limiting exposure, negotiating to settle allegations, or moving to trial when necessary.
No two cases are the same, and every defense must be customized. Our goal is always to resolve the case as efficiently and quietly as possible while protecting our clients’ licenses, reputations, and ability to practice medicine. However, it is important to recognize the significant risks associated with FCA litigation, including substantial financial penalties and reputational harm.
The penalties for violating the False Claims Act can be severe, especially for healthcare providers who depend on continued participation in federal programs. Even when the underlying conduct is the result of a documentation error or a disputed interpretation of billing rules, the financial and professional consequences can be life-changing. In a False Claims Act case, the government can seek recovered funds, which may include substantial amounts depending on the scope of the alleged fraud.
Under the False Claims Act, penalties may include:
Many actions begin as whistleblower claims, where individuals report suspected fraud under the federal False Claims Act. A False Claims Act lawsuit is a complex legal process that allows whistleblowers to bring allegations on behalf of the government, and the government may choose to intervene based on the strength of the case.
For healthcare professionals, the threat is not just financial. A False Claims Act judgment or settlement can lead to NPDB reporting, insurance credentialing problems, and long-term harm to your career. In some cases, relators may attempt to leverage the lawsuit to create pressure for parallel civil claims or business disputes.
Early intervention and an informed defense strategy can often reduce or eliminate exposure. Many of these cases settle without trial when the defense can show the claim was not material, the provider lacked intent, or the allegations stem from good faith disagreements in documentation or medical judgment.
If you’re facing potential FCA liability, it’s essential to work with an act lawyer experienced in FCA defense who understands not only federal law but also how those penalties interact with your licensure, billing privileges, and professional future.
False Claims Act defense is not general litigation. It demands an understanding of federal enforcement, medical billing, healthcare compliance, and the nuanced regulatory environment providers operate within. At Chapman Law Group, we bring together all of these elements with a single focus: defending healthcare professionals—including those involved in qui tam actions, qui tam suits, and representing qui tam relators in complex government fraud matters.
We are not a general practice firm. We exclusively represent licensed healthcare providers across the United States who are facing government investigations, qui tam lawsuits, or False Claims Act allegations involving government contracts, government contractors, government contracting, and defense contractor fraud. Our experience extends to cases involving government fraud and compliance with the requirements of the United States government.
What sets us apart:
Whether you are a physician, pharmacist, clinic administrator, or executive, we understand what’s at stake. Your ability to practice medicine, maintain your license, and continue participating in federal healthcare programs depends on the outcome of your case. We routinely work with federal law enforcement agencies, such as the FBI and the Department of Health and Human Services, who investigate and enforce FCA violations on behalf of the United States government.
Our team is equipped to handle everything from initial government contact to trial. And in every case, our priority is to resolve the matter quickly, discreetly, and in a way that protects your career.
If you’ve been named in a qui tam lawsuit or contacted by federal investigators, understanding the qui tam process and the legal process involved in False Claims Act (FCA) cases is crucial. False Claims Act investigations are serious, and early missteps can make the situation worse. The best protection is immediate, informed action.
Here’s what you should do if you suspect or know you are under investigation:
Time is critical in these matters. The earlier your defense team is involved, the more control you can retain over the process. In many cases, we are able to respond to civil investigative demands, communicate with the Department of Justice, and resolve questions before the case becomes public or escalates to litigation.
If you are facing the possibility of filing a qui tam lawsuit or responding to one, it is important to understand the steps involved, including filing under seal, the government’s investigation, and the potential for intervention. Legal guidance is essential at every stage to ensure your rights are protected and to navigate the complexities of the qui tam process.
At Chapman Law Group, we offer urgent consultations for healthcare providers facing FCA exposure. Whether you’ve received a subpoena, a target letter, or informal inquiry, we’re here to help you navigate your options and begin building your defense.
If you are under investigation for violating the False Claims Act or have been named in a qui tam lawsuit, now is the time to act. These cases move quickly once unsealed, and early decisions can have lasting consequences for your license, reputation, and financial future.
Chapman Law Group is a national healthcare defense law firm dedicated exclusively to representing licensed medical professionals. Our team is experienced in handling False Claims Act cases at every stage, from pre-intervention investigations to trial defense.
We understand the unique challenges healthcare providers face when navigating federal allegations. Whether you’re a solo practitioner, clinic owner, executive, or part of a large practice group, we are ready to provide the legal strategy and support you need.
Contact us today to schedule a confidential consultation with a member of our FCA defense practice. We are available for urgent matters and can help you understand your options, evaluate the risks, and begin building a strong defense.
Most cases are triggered by internal whistleblowers, often former employees who claim to have witnessed fraudulent billing, improper referrals, or regulatory noncompliance. Other triggers include audit findings, competitor complaints, or data anomalies that draw government attention.
In most situations, no. Because the claims involve government funds, any resolution must be approved by the Department of Justice. However, strategic negotiation before or after intervention can lead to favorable settlements. Having experienced FCA defense counsel involved early can make a significant difference.
Civil FCA cases focus on financial penalties and program exclusion. Criminal charges are less common and typically involve clear evidence of intentional fraud or obstruction. While most qui tam cases remain civil, certain fact patterns, especially those involving altered records or repeated misconduct can trigger criminal scrutiny.
Yes. State licensing boards may open investigations based on allegations of fraud, even before a case is resolved. A civil settlement or government report can lead to disciplinary action, public censure, or license suspension. Coordinating your FCA defense with licensing counsel is essential.
Qui tam investigations can remain under seal for 12 to 24 months while the government decides whether to intervene. Once the case is unsealed, litigation can extend for months or years depending on its complexity. That’s why early action and experienced representation are critical to protecting your interests.
"*" indicates required fields
In 2022, prosecutors charged a pharmacy owner with $14.5 million Medicare kickbacks. They alleged they paid kickbacks to telemarketing …….
Following review of our physician’s compliance plan, the government choose to dismiss the investigation without taking any adverse action.
Instead of potentially facing charges under the False Claims Act, the provider was paid the governmental incentive for properly achieving meaningful use or the exclusions thereunder.
New healthcare business ventures can easily, sometimes unknowingly run afoul of Stark Law, Anti-Kickback, and the False Claims Act. Here’s how to be sure you are being fully compliant and not violating any state and federal laws.
Here’s why it’s important to take a closer look at whether your medical practice is staying compliant — and not engaging in kickbacks in health care.
Table of Contents DOJ Has Recovered $34 Billion Since 1986. Settlements Can Reach in the Millions. As a Licensed Medical Professional, What Should You Know?
